Predictive Biomarkers of Response to Nivolumab in Non-Small Cell Lung Cancer: A Multicenter Retrospective Cohort Study

被引：0
|
作者：
Kataoka, Y. [1 ]
Hirano, K. [1 ]
Narabayashi, T. [2 ]
Hara, S. [3 ]
Fujimoto, D. [4 ]
Tanaka, T. [5 ]
Ebi, N. [6 ]
Tomii, K. [4 ]
Yoshioka, H. [5 ]
机构：
[1] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Resp Med, Amagasaki, Hyogo, Japan
[2] Jcho Osaka Hosp, Osaka, Japan
[3] Itami City Hosp, Dept Internal Med, Itami, Hyogo, Japan
[4] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan
[5] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan
[6] Iizuka Hosp, Dept Resp Med, Iizuka, Fukuoka, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
immunotherapy; NSCLC; biomarker;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.07-004
引用
收藏
页码：S1995 / S1995
页数：1
相关论文
共 50 条
  • [31] Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study
    Liguori, Luigi
    Giorgio, Gabriele
    Polcaro, Giovanna
    Pagliara, Valentina
    Malandrino, Domenico
    Perri, Francesco
    Cascella, Marco
    Ottaiano, Alessandro
    Conti, Valeria
    Servetto, Alberto
    Bianco, Roberto
    Pepe, Stefano
    Sabbatino, Francesco
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [32] Research progress of extracellular vesicles as biomarkers in immunotherapy for non-small cell lung cancer
    Ge, Yang
    Ye, Ting
    Fu, Siyun
    Jiang, Xiaoying
    Song, Hang
    Liu, Bin
    Wang, Guoquan
    Wang, Jinghui
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [33] Biomarkers of immunotherapy in non-small cell lung cancer
    Wang, Lingling
    Hu, Yue
    Wang, Shengchao
    Shen, Jiali
    Wang, Xiaochen
    ONCOLOGY LETTERS, 2020, 20 (05)
  • [34] Efficacy and safety of immunoradiotherapy for advanced non-small cell lung cancer: a retrospective comparative cohort study
    Gao, Titan
    Sun, Xiaorong
    Hou, Yichen
    Zhang, Mingzhu
    Tan, Weiyue
    Zhang, Yi
    Wang, Jie
    Zheng, Zhonghang
    Li, Chaozhuo
    Qi, Haoran
    Hu, Mengyu
    Xin, Ligang
    JOURNAL OF THORACIC DISEASE, 2023, 15 (06) : 3182 - +
  • [35] Nivolumab: A Review in Advanced Nonsquamous Non-Small Cell Lung Cancer
    Keating, Gillian M.
    DRUGS, 2016, 76 (09) : 969 - 978
  • [36] Factors Associated With Efficacy and Nivolumab-Related Interstitial Pneumonia in Non-Small Cell Lung Cancer: A Retrospective Survey
    Hata, Hiroki
    Mio, Tadashi
    Yamashita, Daisuke
    Matsumura, Chikako
    Chisaki, Yugo
    Motohashi, Hideyuki
    Yano, Yoshitaka
    CANCER CONTROL, 2020, 27 (04)
  • [37] Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC)
    Schmid, Sabine
    Diem, Stefan
    Li, Qiyu
    Krapf, Mirjam
    Flatz, Lukas
    Leschka, Sebastian
    Desbiolles, Lotus
    Klingbiel, Dirk
    Jochum, Wolfram
    Fruh, Martin
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (12) : 1825 - 1832
  • [38] Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC)
    Sabine Schmid
    Stefan Diem
    Qiyu Li
    Mirjam Krapf
    Lukas Flatz
    Sebastian Leschka
    Lotus Desbiolles
    Dirk Klingbiel
    Wolfram Jochum
    Martin Früh
    Cancer Immunology, Immunotherapy, 2018, 67 : 1825 - 1832
  • [39] Nivolumab in Non-Small Cell Lung Cancer (NSCLC): Facing the Reality
    Merimsky, O.
    Shamai, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2425 - S2425
  • [40] Nivolumab in the treatment of metastatic squamous non-small cell lung cancer: a review of the evidence
    Lim, Joline S. J.
    Soo, Ross A.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2016, 10 (05) : 444 - 454
12345